These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18783074)

  • 21. [Noninvasive prenatal diagnosis of single gene disorders through cell-free fetal DNA in maternal blood].
    Guo QW; Zhou YL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Aug; 26(4):410-3. PubMed ID: 20017305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry.
    Li Y; Finning K; Daniels G; Hahn S; Zhong X; Holzgreve W
    Prenat Diagn; 2008 Mar; 28(3):203-8. PubMed ID: 18241084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent progress in non-invasive prenatal diagnosis.
    Hahn S; Zhong XY; Holzgreve W
    Semin Fetal Neonatal Med; 2008 Apr; 13(2):57-62. PubMed ID: 18207470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-free nucleic acids as potential markers for preeclampsia.
    Hahn S; Rusterholz C; Hösli I; Lapaire O
    Placenta; 2011 Feb; 32 Suppl():S17-20. PubMed ID: 21257079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-free fetal nucleic acid testing: a review of the technology and its applications.
    Sayres LC; Cho MK
    Obstet Gynecol Surv; 2011 Jul; 66(7):431-42. PubMed ID: 21944155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in the analysis of fetal nucleic acids in maternal plasma.
    Tsui NB; Lo YM
    Curr Opin Hematol; 2012 Nov; 19(6):462-8. PubMed ID: 22954725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New frontiers in noninvasive, prenatal screening and diagnosis: fetal DNA circulating in maternal blood].
    Montagnana M; Lippi G; Guidi GC
    Minerva Ginecol; 2007 Jun; 59(3):331-41. PubMed ID: 17576408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal screening of single-gene disorders from maternal blood.
    Sekizawa A; Saito H
    Am J Pharmacogenomics; 2001; 1(2):111-7. PubMed ID: 12174672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating nucleic acids in plasma and serum: past, present and future.
    Taback B; Hoon DS
    Curr Opin Mol Ther; 2004 Jun; 6(3):273-8. PubMed ID: 15264429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slovenian five-year experiences with rapid prenatal diagnosis of common chromosome aneuploidies using quantitative-fluorescence polymerase chain reaction.
    Škerget AE; Herodež SS; Zagorac A; Zagradišnik B; Mujezinović F; Vokač NK
    Genet Test Mol Biomarkers; 2013 Sep; 17(9):669-74. PubMed ID: 23786225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Size fractionation of cell-free DNA in maternal plasma and its application in noninvasive detection of fetal single gene point mutations.
    Li Y; Holzgreve W; Hahn S
    Methods Mol Biol; 2008; 444():239-51. PubMed ID: 18425486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fetal nucleic acids in maternal plasma.
    Lo YM
    Ann N Y Acad Sci; 2008 Aug; 1137():140-3. PubMed ID: 18837938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive prenatal diagnosis using cell-free fetal DNA in maternal plasma from PGD pregnancies.
    Li Y; Altarescu G; Renbaum P; Eldar-Geva T; Levy-Lahad E; Margalioth EJ; Zhong X; Hahn S; Holzgreve W
    Reprod Biomed Online; 2009 Nov; 19(5):714-20. PubMed ID: 20021720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Non invasive prenatal diagnosis. Fetal nucleic acid analysis in maternal blood].
    Sesarini C; Argibay P; Otaño L
    Medicina (B Aires); 2010; 70(6):537-42. PubMed ID: 21163745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
    Langlois S; Duncan A; ;
    J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
    Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
    Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay.
    Li Y; Page-Christiaens GC; Gille JJ; Holzgreve W; Hahn S
    Prenat Diagn; 2007 Jan; 27(1):11-7. PubMed ID: 17154237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MALDI-TOF MS as evolving cancer diagnostic tool: a review.
    Rodrigo MA; Zitka O; Krizkova S; Moulick A; Adam V; Kizek R
    J Pharm Biomed Anal; 2014 Jul; 95():245-55. PubMed ID: 24699369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal diagnosis using cell-free nucleic acids in maternal body fluids: a decade of progress.
    Maron JL; Bianchi DW
    Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):5-17. PubMed ID: 17299735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Digital PCR analysis of circulating nucleic acids.
    Hudecova I
    Clin Biochem; 2015 Oct; 48(15):948-56. PubMed ID: 25828047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.